| The J. David Gladstone Institutes |
Level I |
8 | 8 |
$70,762 |
| Gilead Sciences, Inc. |
Level IV |
6 | 6 |
$178,280 |
| Genentech, Inc. |
Level II |
5 | 5 |
$127,000 |
| Genentech, Inc. |
Level III |
5 | 5 |
$140,213 |
| Insitro, Inc. |
Level II |
5 | 5 |
$112,549 |
| Calico Life Sciences LLC |
Level III |
4 | 4 |
$172,000 |
| CZ Biohub SF, LLC |
Level III |
4 | 4 |
$171,500 |
| University of California, San Francisco |
Level I |
4 | 4 |
$126,549 |
| Altos Labs Inc. |
Level III |
3 | 3 |
$142,000 |
| Calico Life Sciences LLC |
Level II |
3 | 3 |
$125,000 |
| CZ Biohub SF, LLC |
Level I |
3 | 3 |
$120,000 |
| Illumina, Inc. |
Level II |
3 | 3 |
$148,500 |
| LatchBio Inc |
Level II |
3 | 3 |
$112,549 |
| REVOLUTION MEDICINES, INC. |
Level III |
3 | 3 |
$168,000 |
| Zitao Liu, M.D., Professional Corporation |
Level IV |
3 | 3 |
$176,800 |
| ABBVIE BIOTHERAPEUTICS INC. |
Level II |
2 | 2 |
$129,000 |
| AbbVie Biotherapeutics Inc. |
Level III |
2 | 2 |
$149,157 |
| Advanced Cell Diagnostics, Inc. |
Level II |
2 | 2 |
$112,549 |
| Alamar Biosciences, Inc. |
Level II |
2 | 2 |
$137,564 |
| Altos Labs Inc. |
Level I |
2 | 2 |
$84,900 |
| Amgen Inc. |
Level I |
2 | 2 |
$118,750 |
| Bio-Rad Laboratories, Inc. |
Level II |
2 | 2 |
$112,549 |
| Buck Institute for Research on Aging |
Level II |
2 | 2 |
$87,692 |
| Calico Life Sciences LLC |
Level IV |
2 | 2 |
$240,000 |
| Codexis Inc. |
Level III |
2 | 2 |
$145,839 |
| Eikon Therapeutics, Inc. |
Level II |
2 | 2 |
$112,549 |
| Genentech, Inc. |
Level I |
2 | 30 |
$85,041 |
| Gilead Sciences, Inc. |
Level II |
2 | 2 |
$125,235 |
| Illumina, Inc. |
Level IV |
2 | 2 |
$181,939 |
| The J David Gladstone Institutes |
Level III |
2 | 2 |
$140,213 |
| Lawrence Berkeley National Laboratory |
Level III |
2 | 2 |
$122,076 |
| Lawrence Livermore National Security, LLC |
Level II |
2 | 2 |
$185,400 |
| Mammoth Biosciences, Inc. |
Level III |
2 | 2 |
$140,213 |
| Maze Therapeutics Inc. |
Level II |
2 | 2 |
$128,050 |
| Natera, Inc. |
Level IV |
2 | 2 |
$167,877 |
| Novartis Institutes for BioMedical Research, Inc. |
Level I |
2 | 2 |
$84,885 |
| Personalis, Inc. |
Level IV |
2 | 2 |
$175,000 |
| Reprogram Biosciences Inc. |
Level I |
2 | 2 |
$125,000 |
| Shanda Asset Management LLC |
Level II |
2 | 2 |
$152,500 |
| TPG Global, LLC |
Level IV |
2 | 2 |
$170,000 |
| Valinor Industries, Inc. |
Level III |
2 | 2 |
$140,213 |
| Weatherwax Biotechnologies Corporation |
Level I |
2 | 2 |
$98,717 |
| 10x Genomics, Inc. |
Level I |
1 | 1 |
$90,000 |
| ABBOTT DIABETES CARE INC. |
Level I |
1 | 1 |
$85,000 |
| AbbVie Biotherapeutics Inc. |
Level I |
1 | 1 |
$106,829 |
| Addition Therapeutics, Inc. |
Level II |
1 | 1 |
$116,800 |
| Addition Therapeutics, Inc. |
Level III |
1 | 1 |
$140,213 |
| Agilent Technologies, Inc. |
Level II |
1 | 1 |
$166,788 |
| Alamar Biosciences, Inc. |
Level I |
1 | 1 |
$91,746 |
| Alamar Biosciences, Inc. |
Level III |
1 | 1 |
$153,725 |
| Allman Institute for Personalized Medicine LLC |
Level II |
1 | 1 |
$112,549 |
| Altos Labs Inc. |
Level II |
1 | 1 |
$142,000 |
| Amgen Inc. |
Level II |
1 | 1 |
$155,100 |
| Apeximmune Therapeutics Inc |
Level I |
1 | 1 |
$95,000 |
| Astera Institute |
Level II |
1 | 1 |
$160,000 |
| BillionToOne, Inc. |
Level I |
1 | 1 |
$110,881 |
| BillionToOne, Inc. |
Level II |
1 | 1 |
$112,549 |
| BillionToOne, Inc. |
Level III |
1 | 1 |
$142,561 |
| BioAge Labs, Inc. |
Level II |
1 | 1 |
$120,000 |
| BIOALGO (USA) LLC |
Level II |
1 | 1 |
$112,549 |
| Biogen, Inc. |
Level II |
1 | 1 |
$112,549 |
| BioMarin Pharmaceutical Inc. |
Level II |
1 | 1 |
$112,549 |
| Bristol-Myers Squibb Company |
Level III |
1 | 1 |
$152,982 |
| BRUKER CELLULAR ANALYSIS, INC. |
Level III |
1 | 1 |
$156,500 |
| Calico Life Sciences LLC |
Level I |
1 | 1 |
$181,000 |
| Calsoft Labs Inc |
Level III |
1 | 1 |
$144,768 |
| Carl Zeiss Meditec, Inc. |
Level III |
1 | 1 |
$157,056 |
| Cartography Biosciences, Inc. |
Level II |
1 | 1 |
$113,000 |
| CHAN ZUCKERBERG BIOHUB, INC |
Level III |
1 | 1 |
$169,000 |
| Clear Labs, Inc. |
Level III |
1 | 1 |
$140,213 |
| Critical Path Institute |
Level II |
1 | 1 |
$112,549 |
| Cytokinetics, Inc. |
Level II |
1 | 1 |
$112,950 |
| CytomX Therapeutics, Inc. |
Level II |
1 | 1 |
$117,916 |
| DNA TwoPointo, Inc. (DBA ATUM) |
Level II |
1 | 1 |
$125,000 |
| Dren Bio Management, Inc. |
Level II |
1 | 1 |
$112,549 |
| E11 Bio, LLC |
Level IV |
1 | 1 |
$168,000 |
| EBVIO INC. |
Level IV |
1 | 1 |
$175,000 |
| EPI Labs Inc. |
Level II |
1 | 1 |
$140,000 |
| Epicrispr Biotechnologies, Inc. |
Level II |
1 | 1 |
$123,000 |
| Epimeron USA, Inc. |
Level III |
1 | 1 |
$145,000 |
| Escalante Biosciences, Inc. |
Level II |
1 | 1 |
$120,000 |
| Firefly Bio Inc. |
Level III |
1 | 1 |
$140,213 |
| Flex Therapeutics Inc. |
Level IV |
1 | 1 |
$245,000 |
| Genentech, Inc. |
Level IV |
1 | 1 |
$167,877 |
| Gilead Sciences, Inc. |
Level III |
1 | 1 |
$140,213 |
| Howard Hughes Medical Institute |
Level I |
1 | 1 |
$76,491 |
| Howard Hughes Medical Institute |
Level II |
1 | 1 |
$85,384 |
| Howard Hughes Medical Institute |
Level III |
1 | 1 |
$121,800 |
| Howard Hughes Medical Institute |
Level IV |
1 | 1 |
$221,083 |
| Illumina, Inc. |
Level I |
1 | 1 |
$86,300 |
| Illumina Software, Inc. |
Level III |
1 | 1 |
$178,800 |
| Insitro, Inc. |
Level III |
1 | 1 |
$140,213 |
| Insitro, Inc. |
Level IV |
1 | 1 |
$167,877 |
| Kite Pharma Inc. |
Level I |
1 | 1 |
$103,200 |
| Ladder Therapeutics INC |
Level I |
1 | 1 |
$104,000 |
| LatchBio Inc |
Level III |
1 | 1 |
$140,213 |
| Lawrence Berkeley National Laboratory |
Level II |
1 | 1 |
$96,000 |
| Lawrence Livermore National Security, LLC |
Level III |
1 | 1 |
$180,992 |
| Lycia Therapeutics, Inc. |
Level I |
1 | 1 |
$100,000 |
| Mammoth Biosciences, Inc. |
Level I |
1 | 1 |
$85,000 |